Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

por Merola, J.F., Ghislain, P.‐D., Dauendorffer, J.N., Potts Bleakman, A., Brnabic, A.J.M., Burge, R., Riedl, E.
Publicado 2020